|
PLBD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.641400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.843300E-03 |
| Normal-vs-Stage2 |
1.557610E-01 |
| Normal-vs-Stage3 |
3.124200E-02 |
| Normal-vs-Stage4 |
9.816200E-03 |
| Stage1-vs-Stage2 |
2.765800E-01 |
| Stage1-vs-Stage3 |
4.393800E-01 |
| Stage1-vs-Stage4 |
9.270000E-01 |
| Stage2-vs-Stage3 |
6.791600E-01 |
| Stage2-vs-Stage4 |
3.474400E-01 |
| Stage3-vs-Stage4 |
5.558200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.777850E-02 |
| Normal-vs-AfricanAmerican |
4.373600E-01 |
| Normal-vs-Asian |
2.639700E-02 |
| Caucasian-vs-AfricanAmerican |
3.500600E-01 |
| Caucasian-vs-Asian |
7.665400E-01 |
| AfricanAmerican-vs-Asian |
2.775800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.058600E-03 |
| Normal-vs-Female |
9.080500E-03 |
| Male-vs-Female |
6.219400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.302500E-03 |
| Normal-vs-Age(41-60Yrs) |
8.175300E-03 |
| Normal-vs-Age(61-80Yrs) |
2.951800E-02 |
| Normal-vs-Age(81-100Yrs) |
5.185700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.540000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.853400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.114200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.619800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.179800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.544000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.780000E-01 |
| Classical-VS-Follicular |
3.362200E-03 |
| Classical-VS-Other |
3.638100E-02 |
| Classical-VS-Normal |
4.804200E-02 |
| Tall-VS-Follicular |
2.983200E-01 |
| Tall-VS-Other |
1.034980E-01 |
| Tall-VS-Normal |
3.727900E-02 |
| Follicular-VS-Other |
3.407200E-01 |
| Follicular-VS-Normal |
1.598200E-04 |
| Other-VS-Normal |
3.075900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.177300E-03 |
| Normal-vs-N1 |
3.987500E-04 |
| N0-vs-N1 |
1.155030E-01 |
|
|
